ASH2019

Novartis still hasn't solved its lingering CAR-T manufacturing issues
Biopharma Dive
Wed, 12/11/19 - 09:59 pm
ASH2019
Novartis
FDA
CAR-T
drug manufacturing
Kymriah
ASH2019 – Regeneron takes the bispecific baton and runs
EP Vantage
Wed, 12/11/19 - 10:21 am
ASH2019
Regeneron
Xencor
bispecific antibodies
REGN1979
lyphoma
Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Tue, 12/10/19 - 11:53 pm
Merck
Eli Lilly
AbbVie
JNJ
Imbruvica
ARQ 531
LOXO-305
CLL
ASH2019
ASH: Sanofi eyes FDA filing as orphan blood drug hits late-phase goal
Fierce Biotech
Tue, 12/10/19 - 10:09 am
Sanofi
clinical trials
sutimlimab
ASH2019
cold agglutinin disease
This Small-Cap Biotech Rose as Much as 98.3% Today
Motley Fool
Mon, 12/9/19 - 11:30 pm
Forty Seven
ASH2019
magrolimab
monoclonal antibodies
AML
ASH: J&J's Darzalex cuts death risk by 40% in new myeloma patients
Fierce Pharma
Mon, 12/9/19 - 11:24 pm
JNJ
Darzalex
Multiple Myeloma
ASH2019
ASH: Takeda details Ninlaro's miss in scrapped AL amyloidosis trial
Fierce Pharma
Mon, 12/9/19 - 09:59 am
ASH2019
Takeda
Nilaro
AL amyloidosis
ASH: Amgen's BiTE stalls multiple myeloma relapse in mice in combo with BMS' Revlimid
Fierce Biotech
Mon, 12/9/19 - 09:53 am
Amgen
ASH2019
bispecific antibodies
AMG 701
Multiple Myeloma
ASH: Roche bispecific delivers for hard-to-treat lymphoma patients failed by CAR-Ts
Fierce Biotech
Mon, 12/9/19 - 09:48 am
Roche
ASH2019
non-Hodgkin lymphoma
mosunetuzumab
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
Fierce Biotech
Sun, 12/8/19 - 10:20 pm
Eli Lilly
Loxo Oncology
ASH2019
CLL
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
Sun, 12/8/19 - 10:17 pm
AstraZeneca
cancer
Calquence
ASH2019
Imbruvica
JNJ
AbbVie
CLL
ASH: Gilead touts 'astounding' Yescarta survival results at 3 years
Fierce Pharma
Sun, 12/8/19 - 10:13 pm
Gilead Sciences
Yescarta
ASH2019
CAR-T
refractory large B-cell lymphoma
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
Fierce Pharma
Sun, 12/8/19 - 10:12 pm
AbbVie
Roche
CLL
ASH2019
Venclexta
Sangamo keeps pressure on rivals with updated hemophilia data
Biopharma Dive
Sat, 12/7/19 - 11:48 pm
ASH2019
Pfizer
Sangamo
hemophilia
SB-525
Myeloma cell therapies, now in pharma hands, move into spotlight
Biopharma Dive
Sat, 12/7/19 - 11:47 pm
ASH2019
cell therapies
Multiple Myeloma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio